t of accumulated depreciation of $1,392,704and $948,445, respectively756,9561,049,597Goodwill857,597857,597Intangible assets, net of accumulated amortization of $2,132,606and $1,464,674, respectively3,929,3944,597,326Deferred financing costs-192,627Deposits and other long term assets102,500189,202Total assets$
7,352,245$
9,692,083LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable and accrued expenses
$
848,286$
29,349Short-term convertible notes, plus accrued interest of $3,432
403,432-Total current liabilities1,251,718629,349Long-term convertible debt, face value $3,472,000, less unamortizeddiscount of $550,748 and including accrued interest of $69,604
-2,990,856Total liabilities1,251,7183,620,205Commitments and contingency (Note 14)
--Stockholders' equity:Preferred stock; $.001 par value; 5,000,000 shares authorized and 0 shares issued and outstanding
--Common stock; $.001 par value; 100,000,000 shares authorized;4,331,910 and 50,002,887 shares issued and outstanding, respectively
64,38250,003Additional paid-in capital57,888,50646,454,482Treasury stock (50,000 shares at cost)
(25,000)(25,000)Accumulated deficit(51,827,360)(40,407,607)Total stockholders' equity
6,100,5286,071,878Total liabilities and stockholders' equity
$
7,352,245$
9,692,083See notes to consolidated financial statements
'/>"/>
SOURCE MiMedx Group, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related biology technology :1.
MiMedx Group Announces Temporary Trading Symbol Designation2.
MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference3.
MiMedx Group, Inc. Announces Release Date For Third Quarter Results4.
MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference5.
MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting6.
MiMedx Announces Launch of AmnioFix™7.
MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference8.
Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice9.
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results10.
China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results11.
KJT Group Positions for Substantial Growth